BARCELONA, Spain — Julio Miranda had never felt the threat of the coronavirus too close. With an appointment for his first COVID-19 jab scheduled for mid-July, the 48-year-old house painter was, like many in the vaccine-abundant developed world, eagerly awaiting the end of his personal pandemic worries. Then a colleague fell ill last month, followed… Read More »
The Coronavirus Outbreak liveLatest Updates Maps and Cases Delta Variant F.A.Q.s C.D.C. School Guidance Advertisement Continue reading the main story Supported by Continue reading the main story Citing the Delta Variant, Pfizer Will Pursue Booster Shots and a New Vaccine Scientists were critical of the announcement, pointing to evidence that the current two-dose regimen is… Read More »
In a statement published hours after Pfizer signaled its intention to file for emergency use authorization for a COVID-19 booster shot, the FDA and Centers for Disease Control and Prevention (CDC) said fully vaccinated Americans “do not need” an extra dose at this time. The health agencies said the U.S. “is fortunate to have highly… Read More »
Having HIV is not an independent risk factor for severe COVID-19 and death amongst patients hospitalised with COVID-19, according to a Zambian study published in the Morbidity and Mortality Weekly Report. However, patients with more severe HIV infection are more likely to develop severe COVID-19 or die of COVID-19 compared to those without complications. “This… Read More »